Clinical Trials Browser

Phase 2 × Liposarcoma × cemiplimab × Clear all

NCT05694871 2026-01-26

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Phase 2 Active not recruiting

Liposarcoma